1. Home
  2. SINT vs IMRN Comparison

SINT vs IMRN Comparison

Compare SINT & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

N/A

Current Price

$2.13

Market Cap

10.9M

Sector

Health Care

ML Signal

N/A

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$1.13

Market Cap

9.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SINT
IMRN
Founded
1996
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
9.4M
IPO Year
2007
2016

Fundamental Metrics

Financial Performance
Metric
SINT
IMRN
Price
$2.13
$1.13
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $9.13
N/A
AVG Volume (30 Days)
29.4K
★ 3.7M
Earning Date
11-12-2026
08-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 59.45
N/A
EPS
N/A
★ N/A
Revenue
★ $1,018,000.00
N/A
Revenue This Year
$190.28
$16.39
Revenue Next Year
$79.38
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.40
$0.68
52 Week High
$4.64
$2.38

Technical Indicators

Market Signals
Indicator
SINT
IMRN
Relative Strength Index (RSI) 66.00 44.88
Support Level $1.83 $1.01
Resistance Level $2.46 $1.22
Average True Range (ATR) 0.16 0.08
MACD 0.04 -0.02
Stochastic Oscillator 64.20 10.53

Price Performance

Historical Comparison
SINT
IMRN

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: